India Glycols Ltd is Rated Hold by MarketsMOJO

Feb 01 2026 10:10 AM IST
share
Share Via
India Glycols Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
India Glycols Ltd is Rated Hold by MarketsMOJO

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for India Glycols Ltd indicates a neutral stance on the stock, suggesting that investors should neither aggressively buy nor sell at this juncture. This rating reflects a balance between the company’s strengths and weaknesses across several key parameters. The Mojo Score, a composite measure of various financial and market factors, currently stands at 50.0, placing the stock in the middle of the rating spectrum. This score improved modestly from 47 to 50 on 16 January 2026, signalling a slight enhancement in the company’s outlook but not enough to warrant a 'Buy' recommendation.

Quality Assessment: Below Average Fundamentals

As of 01 February 2026, India Glycols Ltd exhibits below average quality metrics. The company’s long-term fundamental strength remains weak, with an average Return on Capital Employed (ROCE) of 8.55%. This figure is modest compared to industry benchmarks, reflecting limited efficiency in generating profits from its capital base. Over the past five years, net sales have grown at an annualised rate of 7.92%, while operating profit has increased by 16.92%. Although these growth rates are positive, they are not robust enough to classify the company as a high-quality growth stock.

Additionally, the company’s debt servicing capacity is a concern, with a high Debt to EBITDA ratio of 3.21 times. This elevated leverage ratio suggests that the company carries a significant debt burden relative to its earnings before interest, taxes, depreciation, and amortisation, which could constrain financial flexibility in adverse market conditions.

Valuation: Attractive Pricing Relative to Peers

Despite the below average quality, India Glycols Ltd’s valuation remains attractive as of 01 February 2026. The stock trades at an Enterprise Value to Capital Employed ratio of 1.8, which is lower than the average historical valuations of its peers in the commodity chemicals sector. This discount provides a cushion for investors, potentially offering upside if the company improves its operational performance.

The company’s Return on Capital Employed for the half-year period has risen to 10.2%, indicating some improvement in capital efficiency. Furthermore, the Price/Earnings to Growth (PEG) ratio stands at 1, suggesting that the stock’s price is fairly aligned with its earnings growth prospects. Over the past year, the stock has delivered a total return of 33.61%, closely mirroring the 33.6% growth in profits, which underscores a reasonable correlation between market performance and underlying earnings.

Financial Trend: Positive Momentum in Recent Quarters

The latest data as of 01 February 2026 shows encouraging financial trends for India Glycols Ltd. The company has reported positive results for three consecutive quarters, signalling a sustained recovery or growth phase. Profit After Tax (PAT) for the latest six months stands at ₹138.31 crores, reflecting a healthy growth rate of 25.63% compared to previous periods.

Moreover, the half-year ROCE has improved to 11.46%, the highest in recent times, indicating better utilisation of capital. The Debtors Turnover Ratio has also reached a peak of 30.92 times, suggesting efficient management of receivables and improved cash flow dynamics. These positive financial trends support the 'Hold' rating by indicating that while the company is not yet a strong buy, it is stabilising and showing signs of operational improvement.

Technical Outlook: Mildly Bullish Signals

From a technical perspective, India Glycols Ltd exhibits mildly bullish characteristics as of 01 February 2026. The stock price has shown resilience with a one-day gain of 0.5% and a one-week return of 8.66%. However, the one-month and three-month returns have been negative at -12.70% and -9.00% respectively, reflecting some short-term volatility. The six-month return is positive at 5.76%, but the year-to-date performance remains subdued at -13.46%.

These mixed signals suggest that while there is some upward momentum, investors should remain cautious and monitor price movements closely. The technical grade aligns with the overall 'Hold' rating, indicating neither strong bullish nor bearish trends dominate the stock currently.

Investor Considerations and Market Position

India Glycols Ltd is classified as a small-cap company within the commodity chemicals sector. Despite its size, domestic mutual funds hold a relatively small stake of just 0.68%. Given that mutual funds typically conduct thorough research before investing, this limited exposure may indicate a cautious stance towards the stock, possibly due to concerns over valuation or business fundamentals.

Investors should weigh the company’s attractive valuation and improving financial trends against its below average quality and leverage concerns. The 'Hold' rating suggests that the stock may be suitable for investors seeking exposure to the commodity chemicals sector without taking on excessive risk, but it does not currently warrant an aggressive buy position.

Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!

  • - Latest weekly selection
  • - Target price delivered
  • - Large Cap special pick

See This Week's Special Pick →

Summary and Outlook

In summary, India Glycols Ltd’s 'Hold' rating by MarketsMOJO, last updated on 16 January 2026, reflects a balanced view of the company’s current standing as of 01 February 2026. The stock presents an attractive valuation and positive recent financial trends, but these are tempered by below average quality metrics and a relatively high debt burden. Technical indicators suggest mild bullishness but also highlight recent volatility.

For investors, this rating implies that India Glycols Ltd may be a reasonable holding within a diversified portfolio, particularly for those who value valuation discounts and improving earnings momentum. However, cautious monitoring of the company’s debt levels and operational performance is advisable before considering any increase in exposure.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
46 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
46 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
46 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
46 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
46 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
46 minutes ago
share
Share Via